David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,358
Out of 4,818 analysts
6
Total ratings
n/a
Success rate
-61.2%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $15 | $1.53 | +880.39% | 2 | Dec 5, 2024 | |
| STSS Sharps Technology | Initiates: Buy | $352 | $0.02 | +1,644,759.81% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.64 | +1,945.31% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $1.19 | +10,068.07% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Dec 5, 2024
Reiterates: Buy
Price Target: $15
Current: $1.53
Upside: +880.39%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $352
Current: $0.02
Upside: +1,644,759.81%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.64
Upside: +1,945.31%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.19
Upside: +10,068.07%